Lakefront Biotherapeutics American Depositary Shares — Institutional Ownership
Which tracked institutions hold LKFT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$518505972
Total value held
Buying
6 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | $500157715 | 16707477 | — | Held |
| 2 | Blackrock, Inc. | $10137797 | 338152 | +26046 | +8.35% |
| 3 | Ubs Group Ag | $5041077 | 168148 | +168148 | NEW BUY |
| 4 | Goldman Sachs Group Inc | $1696298 | 56581 | +11210 | +24.71% |
| 5 | Morgan Stanley | $1129706 | 37682 | +11063 | +41.56% |
| 6 | Bank Of America Corp /De/ | $225720 | 7529 | -13196 | -63.67% |
| 7 | Jpmorgan Chase & Co | $39164 | 1320 | +1170 | +780.00% |
| 8 | Wells Fargo & Company/Mn | $35976 | 1200 | — | Held |
| 9 | Royal Bank Of Canada | $26000 | 867 | +195 | +29.02% |
| 10 | Citigroup Inc | $10613 | 354 | -50 | -12.38% |
| 11 | Barclays Plc | $3568 | 119 | -59 | -33.15% |
| 12 | Us Bancorp \De\ | $2338 | 78 | -66 | -45.83% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.